The phosphatidylinositol-3-kinase (PI3K) pathway has been shown to be constitutively active in the majority of multiple myeloma (MM) and acute myeloid leukaemia (AML) cells [1,2,3] and is critical for the tumour cell growth and survival [4,5,6]. This evidence concerns the gene PIK3CA and Miyoshi myopathy.